nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—Myelosuppression—Glyburide—gestational diabetes	0.0119	0.142	CcSEcCtD
Bosutinib—Drug eruption—Glyburide—gestational diabetes	0.00907	0.108	CcSEcCtD
Bosutinib—Hepatic function abnormal—Glyburide—gestational diabetes	0.00463	0.0551	CcSEcCtD
Bosutinib—Renal failure acute—Glyburide—gestational diabetes	0.00439	0.0522	CcSEcCtD
Bosutinib—Renal impairment—Glyburide—gestational diabetes	0.00425	0.0506	CcSEcCtD
Bosutinib—Pancytopenia—Glyburide—gestational diabetes	0.00332	0.0395	CcSEcCtD
Bosutinib—Agranulocytosis—Glyburide—gestational diabetes	0.00291	0.0346	CcSEcCtD
Bosutinib—Hepatitis—Glyburide—gestational diabetes	0.0028	0.0333	CcSEcCtD
Bosutinib—Malnutrition—Glyburide—gestational diabetes	0.00244	0.029	CcSEcCtD
Bosutinib—Anaemia—Glyburide—gestational diabetes	0.00225	0.0268	CcSEcCtD
Bosutinib—Leukopenia—Glyburide—gestational diabetes	0.00218	0.026	CcSEcCtD
Bosutinib—PKMYT1—head—gestational diabetes	0.00211	0.00397	CbGeAlD
Bosutinib—PTK2—embryo—gestational diabetes	0.0021	0.00396	CbGeAlD
Bosutinib—FES—vagina—gestational diabetes	0.00209	0.00393	CbGeAlD
Bosutinib—VRK2—vagina—gestational diabetes	0.00209	0.00393	CbGeAlD
Bosutinib—Myalgia—Glyburide—gestational diabetes	0.00208	0.0247	CcSEcCtD
Bosutinib—Arthralgia—Glyburide—gestational diabetes	0.00208	0.0247	CcSEcCtD
Bosutinib—CLK3—head—gestational diabetes	0.00206	0.00388	CbGeAlD
Bosutinib—STK4—adipose tissue—gestational diabetes	0.00205	0.00387	CbGeAlD
Bosutinib—STK24—uterus—gestational diabetes	0.00205	0.00387	CbGeAlD
Bosutinib—SYK—vagina—gestational diabetes	0.00204	0.00386	CbGeAlD
Bosutinib—TNIK—vagina—gestational diabetes	0.00204	0.00386	CbGeAlD
Bosutinib—CAMK1D—adipose tissue—gestational diabetes	0.00203	0.00383	CbGeAlD
Bosutinib—CDK2—vagina—gestational diabetes	0.00203	0.00382	CbGeAlD
Bosutinib—RPS6KB1—embryo—gestational diabetes	0.00202	0.00381	CbGeAlD
Bosutinib—EPHB2—head—gestational diabetes	0.00201	0.00379	CbGeAlD
Bosutinib—PHKG1—head—gestational diabetes	0.00201	0.00379	CbGeAlD
Bosutinib—STK26—vagina—gestational diabetes	0.00201	0.00378	CbGeAlD
Bosutinib—FGR—embryo—gestational diabetes	0.00201	0.00378	CbGeAlD
Bosutinib—STK24—adipose tissue—gestational diabetes	0.00201	0.00378	CbGeAlD
Bosutinib—Oedema—Glyburide—gestational diabetes	0.00199	0.0237	CcSEcCtD
Bosutinib—SLK—islet of Langerhans—gestational diabetes	0.00199	0.00375	CbGeAlD
Bosutinib—EPHB4—islet of Langerhans—gestational diabetes	0.00197	0.00372	CbGeAlD
Bosutinib—SRMS—head—gestational diabetes	0.00197	0.00371	CbGeAlD
Bosutinib—Nervous system disorder—Glyburide—gestational diabetes	0.00195	0.0232	CcSEcCtD
Bosutinib—Thrombocytopenia—Glyburide—gestational diabetes	0.00195	0.0232	CcSEcCtD
Bosutinib—TXK—head—gestational diabetes	0.00195	0.00367	CbGeAlD
Bosutinib—FER—adipose tissue—gestational diabetes	0.00194	0.00366	CbGeAlD
Bosutinib—CHEK2—vagina—gestational diabetes	0.00194	0.00366	CbGeAlD
Bosutinib—EPHA2—islet of Langerhans—gestational diabetes	0.00194	0.00365	CbGeAlD
Bosutinib—EPHA8—head—gestational diabetes	0.00193	0.00363	CbGeAlD
Bosutinib—DMPK—vagina—gestational diabetes	0.00192	0.00363	CbGeAlD
Bosutinib—WEE1—vagina—gestational diabetes	0.00192	0.00363	CbGeAlD
Bosutinib—TNK2—uterus—gestational diabetes	0.00191	0.00359	CbGeAlD
Bosutinib—MAP4K1—adipose tissue—gestational diabetes	0.0019	0.00358	CbGeAlD
Bosutinib—BTK—adipose tissue—gestational diabetes	0.00189	0.00357	CbGeAlD
Bosutinib—MAP4K5—islet of Langerhans—gestational diabetes	0.00189	0.00356	CbGeAlD
Bosutinib—SYK—head—gestational diabetes	0.00189	0.00356	CbGeAlD
Bosutinib—MAP4K2—uterus—gestational diabetes	0.00188	0.00354	CbGeAlD
Bosutinib—CDK2—head—gestational diabetes	0.00187	0.00353	CbGeAlD
Bosutinib—FYN—embryo—gestational diabetes	0.00187	0.00353	CbGeAlD
Bosutinib—TNK2—adipose tissue—gestational diabetes	0.00186	0.00352	CbGeAlD
Bosutinib—STK3—uterus—gestational diabetes	0.00185	0.0035	CbGeAlD
Bosutinib—STK26—head—gestational diabetes	0.00185	0.0035	CbGeAlD
Bosutinib—MAP4K2—adipose tissue—gestational diabetes	0.00184	0.00347	CbGeAlD
Bosutinib—STK25—vagina—gestational diabetes	0.00184	0.00346	CbGeAlD
Bosutinib—ERBB4—adipose tissue—gestational diabetes	0.00181	0.00342	CbGeAlD
Bosutinib—STK3—adipose tissue—gestational diabetes	0.00181	0.00342	CbGeAlD
Bosutinib—Musculoskeletal discomfort—Glyburide—gestational diabetes	0.00181	0.0216	CcSEcCtD
Bosutinib—PLK2—vagina—gestational diabetes	0.00178	0.00337	CbGeAlD
Bosutinib—BMPR2—uterus—gestational diabetes	0.00178	0.00335	CbGeAlD
Bosutinib—WEE1—head—gestational diabetes	0.00178	0.00335	CbGeAlD
Bosutinib—DMPK—head—gestational diabetes	0.00178	0.00335	CbGeAlD
Bosutinib—Dyspnoea—Glyburide—gestational diabetes	0.00177	0.0211	CcSEcCtD
Bosutinib—EPHB3—uterus—gestational diabetes	0.00176	0.00333	CbGeAlD
Bosutinib—YES1—islet of Langerhans—gestational diabetes	0.00175	0.00329	CbGeAlD
Bosutinib—BMPR2—adipose tissue—gestational diabetes	0.00174	0.00328	CbGeAlD
Bosutinib—Decreased appetite—Glyburide—gestational diabetes	0.00173	0.0206	CcSEcCtD
Bosutinib—STK36—adipose tissue—gestational diabetes	0.00172	0.00325	CbGeAlD
Bosutinib—TAOK3—islet of Langerhans—gestational diabetes	0.00172	0.00325	CbGeAlD
Bosutinib—Gastrointestinal disorder—Glyburide—gestational diabetes	0.00172	0.0204	CcSEcCtD
Bosutinib—MAP4K4—uterus—gestational diabetes	0.00171	0.00323	CbGeAlD
Bosutinib—MERTK—adipose tissue—gestational diabetes	0.0017	0.00321	CbGeAlD
Bosutinib—BCR—uterus—gestational diabetes	0.0017	0.0032	CbGeAlD
Bosutinib—STK25—head—gestational diabetes	0.0017	0.0032	CbGeAlD
Bosutinib—CAMK1D—vagina—gestational diabetes	0.00169	0.00318	CbGeAlD
Bosutinib—EPHA3—head—gestational diabetes	0.00168	0.00317	CbGeAlD
Bosutinib—SRC—islet of Langerhans—gestational diabetes	0.00168	0.00317	CbGeAlD
Bosutinib—MAP4K4—adipose tissue—gestational diabetes	0.00167	0.00316	CbGeAlD
Bosutinib—STK24—vagina—gestational diabetes	0.00167	0.00314	CbGeAlD
Bosutinib—BCR—adipose tissue—gestational diabetes	0.00166	0.00313	CbGeAlD
Bosutinib—NUAK2—adipose tissue—gestational diabetes	0.00166	0.00313	CbGeAlD
Bosutinib—MAP3K12—adipose tissue—gestational diabetes	0.00165	0.00311	CbGeAlD
Bosutinib—PLK2—head—gestational diabetes	0.00165	0.00311	CbGeAlD
Bosutinib—CSK—uterus—gestational diabetes	0.00164	0.0031	CbGeAlD
Bosutinib—Feeling abnormal—Glyburide—gestational diabetes	0.00164	0.0195	CcSEcCtD
Bosutinib—SIK3—head—gestational diabetes	0.00164	0.00309	CbGeAlD
Bosutinib—CSNK1A1—uterus—gestational diabetes	0.00163	0.00308	CbGeAlD
Bosutinib—Gastrointestinal pain—Glyburide—gestational diabetes	0.00163	0.0194	CcSEcCtD
Bosutinib—SRC—embryo—gestational diabetes	0.00162	0.00306	CbGeAlD
Bosutinib—HCK—uterus—gestational diabetes	0.00162	0.00306	CbGeAlD
Bosutinib—CLK1—uterus—gestational diabetes	0.00162	0.00306	CbGeAlD
Bosutinib—MAP2K1—adipose tissue—gestational diabetes	0.00162	0.00305	CbGeAlD
Bosutinib—STK35—adipose tissue—gestational diabetes	0.00162	0.00305	CbGeAlD
Bosutinib—FER—vagina—gestational diabetes	0.00161	0.00304	CbGeAlD
Bosutinib—EPHA5—vagina—gestational diabetes	0.00161	0.00304	CbGeAlD
Bosutinib—CSK—adipose tissue—gestational diabetes	0.00161	0.00303	CbGeAlD
Bosutinib—CSNK1A1—adipose tissue—gestational diabetes	0.0016	0.00301	CbGeAlD
Bosutinib—CAMK2G—uterus—gestational diabetes	0.00159	0.003	CbGeAlD
Bosutinib—HCK—adipose tissue—gestational diabetes	0.00158	0.00299	CbGeAlD
Bosutinib—CLK1—adipose tissue—gestational diabetes	0.00158	0.00299	CbGeAlD
Bosutinib—Urticaria—Glyburide—gestational diabetes	0.00158	0.0188	CcSEcCtD
Bosutinib—MAP4K1—vagina—gestational diabetes	0.00158	0.00298	CbGeAlD
Bosutinib—STK4—head—gestational diabetes	0.00158	0.00297	CbGeAlD
Bosutinib—ABL2—adipose tissue—gestational diabetes	0.00158	0.00297	CbGeAlD
Bosutinib—Abdominal pain—Glyburide—gestational diabetes	0.00157	0.0187	CcSEcCtD
Bosutinib—BTK—vagina—gestational diabetes	0.00157	0.00296	CbGeAlD
Bosutinib—EGFR—uterus—gestational diabetes	0.00157	0.00296	CbGeAlD
Bosutinib—CAMK1D—head—gestational diabetes	0.00156	0.00294	CbGeAlD
Bosutinib—CAMK2G—adipose tissue—gestational diabetes	0.00156	0.00293	CbGeAlD
Bosutinib—BMP2K—adipose tissue—gestational diabetes	0.00156	0.00293	CbGeAlD
Bosutinib—LRRK2—adipose tissue—gestational diabetes	0.00154	0.00291	CbGeAlD
Bosutinib—STK24—head—gestational diabetes	0.00154	0.0029	CbGeAlD
Bosutinib—EGFR—adipose tissue—gestational diabetes	0.00154	0.0029	CbGeAlD
Bosutinib—MAP4K2—vagina—gestational diabetes	0.00153	0.00288	CbGeAlD
Bosutinib—CSNK1E—uterus—gestational diabetes	0.00151	0.00285	CbGeAlD
Bosutinib—ERBB4—vagina—gestational diabetes	0.00151	0.00284	CbGeAlD
Bosutinib—STK3—vagina—gestational diabetes	0.00151	0.00284	CbGeAlD
Bosutinib—PTK2B—adipose tissue—gestational diabetes	0.0015	0.00283	CbGeAlD
Bosutinib—FER—head—gestational diabetes	0.00149	0.00281	CbGeAlD
Bosutinib—TYRO3—head—gestational diabetes	0.00149	0.00281	CbGeAlD
Bosutinib—EPHA5—head—gestational diabetes	0.00149	0.00281	CbGeAlD
Bosutinib—ALK—head—gestational diabetes	0.00149	0.00281	CbGeAlD
Bosutinib—SIK1—uterus—gestational diabetes	0.00149	0.00281	CbGeAlD
Bosutinib—LYN—head—gestational diabetes	0.00148	0.00279	CbGeAlD
Bosutinib—CSNK1E—adipose tissue—gestational diabetes	0.00148	0.00279	CbGeAlD
Bosutinib—EPHA4—uterus—gestational diabetes	0.00147	0.00278	CbGeAlD
Bosutinib—MAP3K19—head—gestational diabetes	0.00146	0.00275	CbGeAlD
Bosutinib—ERBB3—uterus—gestational diabetes	0.00146	0.00275	CbGeAlD
Bosutinib—CSF1R—embryo—gestational diabetes	0.00146	0.00275	CbGeAlD
Bosutinib—SIK1—adipose tissue—gestational diabetes	0.00146	0.00274	CbGeAlD
Bosutinib—IRAK4—adipose tissue—gestational diabetes	0.00146	0.00274	CbGeAlD
Bosutinib—MAP2K2—uterus—gestational diabetes	0.00145	0.00274	CbGeAlD
Bosutinib—ULK3—uterus—gestational diabetes	0.00145	0.00274	CbGeAlD
Bosutinib—BMPR2—vagina—gestational diabetes	0.00145	0.00273	CbGeAlD
Bosutinib—MAP3K2—uterus—gestational diabetes	0.00144	0.00272	CbGeAlD
Bosutinib—EPHA4—adipose tissue—gestational diabetes	0.00144	0.00272	CbGeAlD
Bosutinib—EPHB3—vagina—gestational diabetes	0.00143	0.0027	CbGeAlD
Bosutinib—STK36—vagina—gestational diabetes	0.00143	0.0027	CbGeAlD
Bosutinib—TNK2—head—gestational diabetes	0.00143	0.0027	CbGeAlD
Bosutinib—MAP3K7—uterus—gestational diabetes	0.00143	0.0027	CbGeAlD
Bosutinib—Asthenia—Glyburide—gestational diabetes	0.00143	0.017	CcSEcCtD
Bosutinib—ERBB3—adipose tissue—gestational diabetes	0.00143	0.00269	CbGeAlD
Bosutinib—MAP2K2—adipose tissue—gestational diabetes	0.00142	0.00268	CbGeAlD
Bosutinib—ULK3—adipose tissue—gestational diabetes	0.00142	0.00268	CbGeAlD
Bosutinib—MERTK—vagina—gestational diabetes	0.00142	0.00267	CbGeAlD
Bosutinib—PTK2—uterus—gestational diabetes	0.00141	0.00267	CbGeAlD
Bosutinib—MAP3K2—adipose tissue—gestational diabetes	0.00141	0.00266	CbGeAlD
Bosutinib—Pruritus—Glyburide—gestational diabetes	0.00141	0.0168	CcSEcCtD
Bosutinib—MAP3K7—adipose tissue—gestational diabetes	0.0014	0.00264	CbGeAlD
Bosutinib—STK3—head—gestational diabetes	0.00139	0.00263	CbGeAlD
Bosutinib—ERBB4—head—gestational diabetes	0.00139	0.00263	CbGeAlD
Bosutinib—MAP4K4—vagina—gestational diabetes	0.00139	0.00262	CbGeAlD
Bosutinib—PTK2—adipose tissue—gestational diabetes	0.00138	0.00261	CbGeAlD
Bosutinib—TBK1—adipose tissue—gestational diabetes	0.00138	0.00261	CbGeAlD
Bosutinib—NUAK2—vagina—gestational diabetes	0.00138	0.0026	CbGeAlD
Bosutinib—BCR—vagina—gestational diabetes	0.00138	0.0026	CbGeAlD
Bosutinib—ROCK1—head—gestational diabetes	0.00137	0.00259	CbGeAlD
Bosutinib—MAP3K12—vagina—gestational diabetes	0.00137	0.00259	CbGeAlD
Bosutinib—Diarrhoea—Glyburide—gestational diabetes	0.00136	0.0162	CcSEcCtD
Bosutinib—IRAK1—adipose tissue—gestational diabetes	0.00136	0.00256	CbGeAlD
Bosutinib—LCK—uterus—gestational diabetes	0.00135	0.00255	CbGeAlD
Bosutinib—AXL—uterus—gestational diabetes	0.00135	0.00254	CbGeAlD
Bosutinib—STK35—vagina—gestational diabetes	0.00134	0.00253	CbGeAlD
Bosutinib—PDGFRB—islet of Langerhans—gestational diabetes	0.00134	0.00252	CbGeAlD
Bosutinib—BMPR2—head—gestational diabetes	0.00134	0.00252	CbGeAlD
Bosutinib—CSK—vagina—gestational diabetes	0.00133	0.00252	CbGeAlD
Bosutinib—RPS6KB1—adipose tissue—gestational diabetes	0.00133	0.00251	CbGeAlD
Bosutinib—CSNK1A1—vagina—gestational diabetes	0.00133	0.0025	CbGeAlD
Bosutinib—EPHB3—head—gestational diabetes	0.00132	0.0025	CbGeAlD
Bosutinib—STK36—head—gestational diabetes	0.00132	0.0025	CbGeAlD
Bosutinib—LCK—adipose tissue—gestational diabetes	0.00132	0.00249	CbGeAlD
Bosutinib—FGR—adipose tissue—gestational diabetes	0.00132	0.00249	CbGeAlD
Bosutinib—HCK—vagina—gestational diabetes	0.00132	0.00248	CbGeAlD
Bosutinib—CLK1—vagina—gestational diabetes	0.00132	0.00248	CbGeAlD
Bosutinib—AXL—adipose tissue—gestational diabetes	0.00132	0.00248	CbGeAlD
Bosutinib—ABL2—vagina—gestational diabetes	0.00131	0.00247	CbGeAlD
Bosutinib—MERTK—head—gestational diabetes	0.00131	0.00247	CbGeAlD
Bosutinib—SLK—uterus—gestational diabetes	0.0013	0.00245	CbGeAlD
Bosutinib—CAMK2G—vagina—gestational diabetes	0.00129	0.00244	CbGeAlD
Bosutinib—BMP2K—vagina—gestational diabetes	0.00129	0.00244	CbGeAlD
Bosutinib—PDGFRB—embryo—gestational diabetes	0.00129	0.00244	CbGeAlD
Bosutinib—EPHB4—uterus—gestational diabetes	0.00129	0.00243	CbGeAlD
Bosutinib—MAP4K4—head—gestational diabetes	0.00129	0.00242	CbGeAlD
Bosutinib—LRRK2—vagina—gestational diabetes	0.00128	0.00242	CbGeAlD
Bosutinib—BCR—head—gestational diabetes	0.00128	0.00241	CbGeAlD
Bosutinib—SLK—adipose tissue—gestational diabetes	0.00127	0.00239	CbGeAlD
Bosutinib—MAP3K12—head—gestational diabetes	0.00127	0.00239	CbGeAlD
Bosutinib—Vomiting—Glyburide—gestational diabetes	0.00127	0.0151	CcSEcCtD
Bosutinib—FYN—uterus—gestational diabetes	0.00126	0.00238	CbGeAlD
Bosutinib—EPHB4—adipose tissue—gestational diabetes	0.00126	0.00237	CbGeAlD
Bosutinib—Rash—Glyburide—gestational diabetes	0.00125	0.0149	CcSEcCtD
Bosutinib—Dermatitis—Glyburide—gestational diabetes	0.00125	0.0149	CcSEcCtD
Bosutinib—PTK2B—vagina—gestational diabetes	0.00125	0.00236	CbGeAlD
Bosutinib—Headache—Glyburide—gestational diabetes	0.00125	0.0148	CcSEcCtD
Bosutinib—STK35—head—gestational diabetes	0.00124	0.00234	CbGeAlD
Bosutinib—MAP2K1—head—gestational diabetes	0.00124	0.00234	CbGeAlD
Bosutinib—EPHA2—adipose tissue—gestational diabetes	0.00124	0.00233	CbGeAlD
Bosutinib—FYN—adipose tissue—gestational diabetes	0.00123	0.00233	CbGeAlD
Bosutinib—CSK—head—gestational diabetes	0.00123	0.00232	CbGeAlD
Bosutinib—MAP4K5—uterus—gestational diabetes	0.00123	0.00232	CbGeAlD
Bosutinib—CSNK1E—vagina—gestational diabetes	0.00123	0.00232	CbGeAlD
Bosutinib—CSNK1A1—head—gestational diabetes	0.00122	0.00231	CbGeAlD
Bosutinib—HCK—head—gestational diabetes	0.00122	0.0023	CbGeAlD
Bosutinib—CLK1—head—gestational diabetes	0.00122	0.0023	CbGeAlD
Bosutinib—IRAK4—vagina—gestational diabetes	0.00121	0.00228	CbGeAlD
Bosutinib—MAP3K3—adipose tissue—gestational diabetes	0.00121	0.00227	CbGeAlD
Bosutinib—MAP4K5—adipose tissue—gestational diabetes	0.00121	0.00227	CbGeAlD
Bosutinib—EPHA4—vagina—gestational diabetes	0.0012	0.00226	CbGeAlD
Bosutinib—CAMK2G—head—gestational diabetes	0.00119	0.00225	CbGeAlD
Bosutinib—BMP2K—head—gestational diabetes	0.00119	0.00225	CbGeAlD
Bosutinib—ABL1—islet of Langerhans—gestational diabetes	0.00119	0.00225	CbGeAlD
Bosutinib—LRRK2—head—gestational diabetes	0.00118	0.00223	CbGeAlD
Bosutinib—ULK3—vagina—gestational diabetes	0.00118	0.00223	CbGeAlD
Bosutinib—Nausea—Glyburide—gestational diabetes	0.00118	0.0141	CcSEcCtD
Bosutinib—MAP3K7—vagina—gestational diabetes	0.00116	0.00219	CbGeAlD
Bosutinib—PTK2B—head—gestational diabetes	0.00115	0.00218	CbGeAlD
Bosutinib—ABL1—embryo—gestational diabetes	0.00115	0.00217	CbGeAlD
Bosutinib—TBK1—vagina—gestational diabetes	0.00115	0.00217	CbGeAlD
Bosutinib—PTK2—vagina—gestational diabetes	0.00115	0.00217	CbGeAlD
Bosutinib—YES1—uterus—gestational diabetes	0.00114	0.00215	CbGeAlD
Bosutinib—CSNK1E—head—gestational diabetes	0.00114	0.00214	CbGeAlD
Bosutinib—STK10—uterus—gestational diabetes	0.00113	0.00213	CbGeAlD
Bosutinib—TAOK3—uterus—gestational diabetes	0.00112	0.00212	CbGeAlD
Bosutinib—SIK1—head—gestational diabetes	0.00112	0.00211	CbGeAlD
Bosutinib—IRAK4—head—gestational diabetes	0.00112	0.00211	CbGeAlD
Bosutinib—YES1—adipose tissue—gestational diabetes	0.00111	0.0021	CbGeAlD
Bosutinib—RPS6KB1—vagina—gestational diabetes	0.00111	0.00209	CbGeAlD
Bosutinib—EPHA4—head—gestational diabetes	0.00111	0.00209	CbGeAlD
Bosutinib—STK10—adipose tissue—gestational diabetes	0.0011	0.00208	CbGeAlD
Bosutinib—LCK—vagina—gestational diabetes	0.0011	0.00207	CbGeAlD
Bosutinib—FGR—vagina—gestational diabetes	0.0011	0.00207	CbGeAlD
Bosutinib—TAOK3—adipose tissue—gestational diabetes	0.0011	0.00207	CbGeAlD
Bosutinib—ERBB3—head—gestational diabetes	0.0011	0.00207	CbGeAlD
Bosutinib—AXL—vagina—gestational diabetes	0.0011	0.00207	CbGeAlD
Bosutinib—ULK3—head—gestational diabetes	0.00109	0.00206	CbGeAlD
Bosutinib—MAP2K2—head—gestational diabetes	0.00109	0.00206	CbGeAlD
Bosutinib—MAP3K2—head—gestational diabetes	0.00108	0.00205	CbGeAlD
Bosutinib—SRC—adipose tissue—gestational diabetes	0.00107	0.00202	CbGeAlD
Bosutinib—TBK1—head—gestational diabetes	0.00106	0.002	CbGeAlD
Bosutinib—PTK2—head—gestational diabetes	0.00106	0.002	CbGeAlD
Bosutinib—SLK—vagina—gestational diabetes	0.00105	0.00199	CbGeAlD
Bosutinib—EPHB4—vagina—gestational diabetes	0.00105	0.00197	CbGeAlD
Bosutinib—EPHA2—vagina—gestational diabetes	0.00103	0.00194	CbGeAlD
Bosutinib—FYN—vagina—gestational diabetes	0.00103	0.00193	CbGeAlD
Bosutinib—RPS6KB1—head—gestational diabetes	0.00102	0.00193	CbGeAlD
Bosutinib—FGR—head—gestational diabetes	0.00102	0.00192	CbGeAlD
Bosutinib—AXL—head—gestational diabetes	0.00101	0.00191	CbGeAlD
Bosutinib—MAP4K5—vagina—gestational diabetes	0.001	0.00189	CbGeAlD
Bosutinib—MAP3K3—vagina—gestational diabetes	0.001	0.00189	CbGeAlD
Bosutinib—MAP2K5—adipose tissue—gestational diabetes	0.000985	0.00186	CbGeAlD
Bosutinib—CSF1R—uterus—gestational diabetes	0.000983	0.00185	CbGeAlD
Bosutinib—CSF1R—adipose tissue—gestational diabetes	0.000961	0.00181	CbGeAlD
Bosutinib—EPHA2—head—gestational diabetes	0.000949	0.00179	CbGeAlD
Bosutinib—FYN—head—gestational diabetes	0.000947	0.00179	CbGeAlD
Bosutinib—MAP4K5—head—gestational diabetes	0.000925	0.00174	CbGeAlD
Bosutinib—MAP3K3—head—gestational diabetes	0.000925	0.00174	CbGeAlD
Bosutinib—YES1—vagina—gestational diabetes	0.000925	0.00174	CbGeAlD
Bosutinib—STK10—vagina—gestational diabetes	0.000917	0.00173	CbGeAlD
Bosutinib—TAOK3—vagina—gestational diabetes	0.000913	0.00172	CbGeAlD
Bosutinib—PDGFRB—uterus—gestational diabetes	0.000872	0.00164	CbGeAlD
Bosutinib—YES1—head—gestational diabetes	0.000855	0.00161	CbGeAlD
Bosutinib—PDGFRB—adipose tissue—gestational diabetes	0.000852	0.00161	CbGeAlD
Bosutinib—STK10—head—gestational diabetes	0.000847	0.0016	CbGeAlD
Bosutinib—TAOK3—head—gestational diabetes	0.000844	0.00159	CbGeAlD
Bosutinib—SRC—head—gestational diabetes	0.000822	0.00155	CbGeAlD
Bosutinib—MAP2K5—vagina—gestational diabetes	0.000819	0.00154	CbGeAlD
Bosutinib—CSF1R—vagina—gestational diabetes	0.000799	0.00151	CbGeAlD
Bosutinib—ABL1—uterus—gestational diabetes	0.000777	0.00146	CbGeAlD
Bosutinib—ABL1—adipose tissue—gestational diabetes	0.00076	0.00143	CbGeAlD
Bosutinib—MAP2K5—head—gestational diabetes	0.000756	0.00143	CbGeAlD
Bosutinib—CSF1R—head—gestational diabetes	0.000738	0.00139	CbGeAlD
Bosutinib—PDGFRB—vagina—gestational diabetes	0.000709	0.00134	CbGeAlD
Bosutinib—PDGFRB—head—gestational diabetes	0.000655	0.00123	CbGeAlD
Bosutinib—ABL1—vagina—gestational diabetes	0.000632	0.00119	CbGeAlD
Bosutinib—ABL1—head—gestational diabetes	0.000583	0.0011	CbGeAlD
Bosutinib—ABCB1—islet of Langerhans—gestational diabetes	0.00037	0.000699	CbGeAlD
Bosutinib—ABCB1—embryo—gestational diabetes	0.000358	0.000676	CbGeAlD
Bosutinib—ABCB1—uterus—gestational diabetes	0.000242	0.000456	CbGeAlD
Bosutinib—ABCB1—adipose tissue—gestational diabetes	0.000236	0.000446	CbGeAlD
Bosutinib—ABCB1—vagina—gestational diabetes	0.000196	0.00037	CbGeAlD
Bosutinib—ABCB1—head—gestational diabetes	0.000181	0.000342	CbGeAlD
Bosutinib—SRC—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000115	0.000297	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—MBL2—gestational diabetes	0.000114	0.000295	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—ADIPOQ—gestational diabetes	0.000114	0.000295	CbGpPWpGaD
Bosutinib—ERBB4—Innate Immune System—FGF2—gestational diabetes	0.000113	0.000293	CbGpPWpGaD
Bosutinib—FYN—Signaling by NGF—FGF2—gestational diabetes	0.000113	0.000292	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—RBP4—gestational diabetes	0.000112	0.000292	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—RBP4—gestational diabetes	0.000112	0.000292	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by NGF—FGF2—gestational diabetes	0.000112	0.000291	CbGpPWpGaD
Bosutinib—PRKCQ—Developmental Biology—TNF—gestational diabetes	0.000112	0.00029	CbGpPWpGaD
Bosutinib—MAP2K2—MAPK Signaling Pathway—TNF—gestational diabetes	0.000112	0.000289	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—MTNR1B—gestational diabetes	0.000111	0.000288	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—MBL2—gestational diabetes	0.000111	0.000288	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—LEPR—gestational diabetes	0.00011	0.000286	CbGpPWpGaD
Bosutinib—BCR—Signaling Pathways—LEP—gestational diabetes	0.00011	0.000285	CbGpPWpGaD
Bosutinib—IKBKE—Immune System—FGF2—gestational diabetes	0.00011	0.000285	CbGpPWpGaD
Bosutinib—PDGFRB—MAPK Signaling Pathway—TNF—gestational diabetes	0.000109	0.000282	CbGpPWpGaD
Bosutinib—LYN—Immune System—MBL2—gestational diabetes	0.000109	0.000282	CbGpPWpGaD
Bosutinib—ERBB4—Adaptive Immune System—FGF2—gestational diabetes	0.000109	0.000282	CbGpPWpGaD
Bosutinib—FGR—Innate Immune System—FGF2—gestational diabetes	0.000108	0.000281	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—RBP4—gestational diabetes	0.000108	0.000281	CbGpPWpGaD
Bosutinib—ABL1—Immune System—MBL2—gestational diabetes	0.000108	0.000281	CbGpPWpGaD
Bosutinib—SRC—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000108	0.00028	CbGpPWpGaD
Bosutinib—FYN—Immune System—MBL2—gestational diabetes	0.000107	0.000278	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—MBL2—gestational diabetes	0.000107	0.000276	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—RBP4—gestational diabetes	0.000106	0.000275	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—MTNR1B—gestational diabetes	0.000105	0.000272	CbGpPWpGaD
Bosutinib—BLK—Adaptive Immune System—FGF2—gestational diabetes	0.000104	0.000271	CbGpPWpGaD
Bosutinib—MAP2K1—MAPK Signaling Pathway—TNF—gestational diabetes	0.000104	0.000271	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—RBP4—gestational diabetes	0.000103	0.000268	CbGpPWpGaD
Bosutinib—MAP2K2—Developmental Biology—LEP—gestational diabetes	0.000102	0.000264	CbGpPWpGaD
Bosutinib—PTK2—Developmental Biology—FGF2—gestational diabetes	0.0001	0.000261	CbGpPWpGaD
Bosutinib—FYN—Disease—RBP4—gestational diabetes	9.98e-05	0.000259	CbGpPWpGaD
Bosutinib—ERBB3—Innate Immune System—FGF2—gestational diabetes	9.97e-05	0.000259	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—RBP4—gestational diabetes	9.92e-05	0.000257	CbGpPWpGaD
Bosutinib—YES1—Developmental Biology—FGF2—gestational diabetes	9.91e-05	0.000257	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—MTNR1B—gestational diabetes	9.9e-05	0.000257	CbGpPWpGaD
Bosutinib—EPHA2—Developmental Biology—TNF—gestational diabetes	9.86e-05	0.000256	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—MTNR1B—gestational diabetes	9.76e-05	0.000253	CbGpPWpGaD
Bosutinib—EGFR—Signaling by NGF—FGF2—gestational diabetes	9.73e-05	0.000252	CbGpPWpGaD
Bosutinib—LYN—Developmental Biology—LEP—gestational diabetes	9.73e-05	0.000252	CbGpPWpGaD
Bosutinib—ABL1—Developmental Biology—LEP—gestational diabetes	9.68e-05	0.000251	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—RBP4—gestational diabetes	9.65e-05	0.00025	CbGpPWpGaD
Bosutinib—FER—Signaling Pathways—FGF2—gestational diabetes	9.64e-05	0.00025	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—LEPR—gestational diabetes	9.64e-05	0.00025	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—LEP—gestational diabetes	9.62e-05	0.000249	CbGpPWpGaD
Bosutinib—SYK—Immune System—FGF2—gestational diabetes	9.61e-05	0.000249	CbGpPWpGaD
Bosutinib—ABL1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	9.58e-05	0.000248	CbGpPWpGaD
Bosutinib—FYN—Developmental Biology—LEP—gestational diabetes	9.58e-05	0.000248	CbGpPWpGaD
Bosutinib—ERBB3—Adaptive Immune System—FGF2—gestational diabetes	9.57e-05	0.000248	CbGpPWpGaD
Bosutinib—MAP2K1—Developmental Biology—LEP—gestational diabetes	9.53e-05	0.000247	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—RBP4—gestational diabetes	9.52e-05	0.000247	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—NAMPT—gestational diabetes	9.51e-05	0.000247	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—GCK—gestational diabetes	9.45e-05	0.000245	CbGpPWpGaD
Bosutinib—PRKCQ—Immune System—FGF2—gestational diabetes	9.43e-05	0.000245	CbGpPWpGaD
Bosutinib—MAP2K1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	9.42e-05	0.000244	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—LEPR—gestational diabetes	9.41e-05	0.000244	CbGpPWpGaD
Bosutinib—LCK—Signaling by NGF—FGF2—gestational diabetes	9.38e-05	0.000243	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—NAMPT—gestational diabetes	9.28e-05	0.000241	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—MTNR1B—gestational diabetes	9.26e-05	0.00024	CbGpPWpGaD
Bosutinib—EGFR—Immune System—MBL2—gestational diabetes	9.26e-05	0.00024	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—GCK—gestational diabetes	9.22e-05	0.000239	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—LEPR—gestational diabetes	9.21e-05	0.000239	CbGpPWpGaD
Bosutinib—AXL—Signaling Pathways—FGF2—gestational diabetes	9.14e-05	0.000237	CbGpPWpGaD
Bosutinib—CSK—Immune System—FGF2—gestational diabetes	9.11e-05	0.000236	CbGpPWpGaD
Bosutinib—EGFR—MAPK Signaling Pathway—TNF—gestational diabetes	9.07e-05	0.000235	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—LEPR—gestational diabetes	9.07e-05	0.000235	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—RBP4—gestational diabetes	9.03e-05	0.000234	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—LEPR—gestational diabetes	9.02e-05	0.000234	CbGpPWpGaD
Bosutinib—FYN—Disease—NAMPT—gestational diabetes	8.95e-05	0.000232	CbGpPWpGaD
Bosutinib—LCK—Immune System—MBL2—gestational diabetes	8.92e-05	0.000231	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—NAMPT—gestational diabetes	8.9e-05	0.000231	CbGpPWpGaD
Bosutinib—FYN—Disease—GCK—gestational diabetes	8.89e-05	0.000231	CbGpPWpGaD
Bosutinib—PTK2—Innate Immune System—FGF2—gestational diabetes	8.87e-05	0.00023	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—GCK—gestational diabetes	8.84e-05	0.000229	CbGpPWpGaD
Bosutinib—YES1—Innate Immune System—FGF2—gestational diabetes	8.75e-05	0.000227	CbGpPWpGaD
Bosutinib—BMPR2—Signaling Pathways—FGF2—gestational diabetes	8.72e-05	0.000226	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—MTNR1B—gestational diabetes	8.72e-05	0.000226	CbGpPWpGaD
Bosutinib—PRKCQ—Disease—FGF2—gestational diabetes	8.71e-05	0.000226	CbGpPWpGaD
Bosutinib—CSNK1A1—Disease—FGF2—gestational diabetes	8.71e-05	0.000226	CbGpPWpGaD
Bosutinib—EGFR—Disease—RBP4—gestational diabetes	8.62e-05	0.000223	CbGpPWpGaD
Bosutinib—CYP3A4—Biological oxidations—CYP19A1—gestational diabetes	8.55e-05	0.000222	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—RBP4—gestational diabetes	8.5e-05	0.00022	CbGpPWpGaD
Bosutinib—CYP3A4—Metapathway biotransformation—CYP19A1—gestational diabetes	8.44e-05	0.000219	CbGpPWpGaD
Bosutinib—CSK—Disease—FGF2—gestational diabetes	8.41e-05	0.000218	CbGpPWpGaD
Bosutinib—YES1—Adaptive Immune System—FGF2—gestational diabetes	8.4e-05	0.000218	CbGpPWpGaD
Bosutinib—ABCB1—Allograft Rejection—TNF—gestational diabetes	8.37e-05	0.000217	CbGpPWpGaD
Bosutinib—BCR—Signaling Pathways—FGF2—gestational diabetes	8.36e-05	0.000217	CbGpPWpGaD
Bosutinib—LCK—Disease—RBP4—gestational diabetes	8.31e-05	0.000215	CbGpPWpGaD
Bosutinib—SRC—Signaling by NGF—FGF2—gestational diabetes	8.3e-05	0.000215	CbGpPWpGaD
Bosutinib—IRAK1—Innate Immune System—FGF2—gestational diabetes	8.3e-05	0.000215	CbGpPWpGaD
Bosutinib—EGFR—Developmental Biology—LEP—gestational diabetes	8.27e-05	0.000215	CbGpPWpGaD
Bosutinib—EGFR—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	8.19e-05	0.000212	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—LEP—gestational diabetes	8.18e-05	0.000212	CbGpPWpGaD
Bosutinib—TBK1—Immune System—FGF2—gestational diabetes	8.17e-05	0.000212	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—LEP—gestational diabetes	8.03e-05	0.000208	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—LEP—gestational diabetes	8.03e-05	0.000208	CbGpPWpGaD
Bosutinib—CAMK2G—Immune System—FGF2—gestational diabetes	8.02e-05	0.000208	CbGpPWpGaD
Bosutinib—SRC—Immune System—MBL2—gestational diabetes	7.9e-05	0.000205	CbGpPWpGaD
Bosutinib—MAP3K3—Immune System—FGF2—gestational diabetes	7.83e-05	0.000203	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—LEPR—gestational diabetes	7.83e-05	0.000203	CbGpPWpGaD
Bosutinib—MAP3K7—Innate Immune System—FGF2—gestational diabetes	7.82e-05	0.000203	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—LEP—gestational diabetes	7.75e-05	0.000201	CbGpPWpGaD
Bosutinib—MAP2K2—Developmental Biology—FGF2—gestational diabetes	7.73e-05	0.000201	CbGpPWpGaD
Bosutinib—EGFR—Disease—NAMPT—gestational diabetes	7.73e-05	0.0002	CbGpPWpGaD
Bosutinib—EGFR—Disease—GCK—gestational diabetes	7.68e-05	0.000199	CbGpPWpGaD
Bosutinib—BTK—Immune System—FGF2—gestational diabetes	7.62e-05	0.000198	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—MTNR1B—gestational diabetes	7.62e-05	0.000198	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—LEPR—gestational diabetes	7.55e-05	0.000196	CbGpPWpGaD
Bosutinib—MAP3K7—Adaptive Immune System—FGF2—gestational diabetes	7.51e-05	0.000195	CbGpPWpGaD
Bosutinib—LCK—Disease—NAMPT—gestational diabetes	7.45e-05	0.000193	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—MTNR1B—gestational diabetes	7.44e-05	0.000193	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—RBP4—gestational diabetes	7.43e-05	0.000193	CbGpPWpGaD
Bosutinib—LCK—Disease—GCK—gestational diabetes	7.4e-05	0.000192	CbGpPWpGaD
Bosutinib—ROCK1—Developmental Biology—TNF—gestational diabetes	7.4e-05	0.000192	CbGpPWpGaD
Bosutinib—LYN—Developmental Biology—FGF2—gestational diabetes	7.39e-05	0.000192	CbGpPWpGaD
Bosutinib—ABL1—Developmental Biology—FGF2—gestational diabetes	7.35e-05	0.000191	CbGpPWpGaD
Bosutinib—SRC—Disease—RBP4—gestational diabetes	7.35e-05	0.000191	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—FGF2—gestational diabetes	7.31e-05	0.000189	CbGpPWpGaD
Bosutinib—IRAK4—Immune System—FGF2—gestational diabetes	7.28e-05	0.000189	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—MTNR1B—gestational diabetes	7.28e-05	0.000189	CbGpPWpGaD
Bosutinib—FYN—Developmental Biology—FGF2—gestational diabetes	7.27e-05	0.000189	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—RBP4—gestational diabetes	7.25e-05	0.000188	CbGpPWpGaD
Bosutinib—MAP2K1—Developmental Biology—FGF2—gestational diabetes	7.24e-05	0.000188	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—MTNR1B—gestational diabetes	7.17e-05	0.000186	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—MTNR1B—gestational diabetes	7.13e-05	0.000185	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—RBP4—gestational diabetes	7.1e-05	0.000184	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—LEP—gestational diabetes	7.06e-05	0.000183	CbGpPWpGaD
Bosutinib—CSNK1E—Disease—FGF2—gestational diabetes	7.04e-05	0.000182	CbGpPWpGaD
Bosutinib—HCK—Immune System—FGF2—gestational diabetes	6.99e-05	0.000181	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—RBP4—gestational diabetes	6.99e-05	0.000181	CbGpPWpGaD
Bosutinib—SRC—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	6.98e-05	0.000181	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—RBP4—gestational diabetes	6.95e-05	0.00018	CbGpPWpGaD
Bosutinib—ABCB1—Transmembrane transport of small molecules—GCK—gestational diabetes	6.93e-05	0.00018	CbGpPWpGaD
Bosutinib—MAP2K2—Innate Immune System—FGF2—gestational diabetes	6.83e-05	0.000177	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—GGCT—gestational diabetes	6.82e-05	0.000177	CbGpPWpGaD
Bosutinib—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	6.78e-05	0.000176	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—LEPR—gestational diabetes	6.68e-05	0.000173	CbGpPWpGaD
Bosutinib—PDGFRB—Innate Immune System—FGF2—gestational diabetes	6.67e-05	0.000173	CbGpPWpGaD
Bosutinib—SRC—Disease—NAMPT—gestational diabetes	6.59e-05	0.000171	CbGpPWpGaD
Bosutinib—ERBB4—Immune System—FGF2—gestational diabetes	6.59e-05	0.000171	CbGpPWpGaD
Bosutinib—SRC—Disease—GCK—gestational diabetes	6.55e-05	0.00017	CbGpPWpGaD
Bosutinib—LYN—Innate Immune System—FGF2—gestational diabetes	6.53e-05	0.000169	CbGpPWpGaD
Bosutinib—ABL1—Innate Immune System—FGF2—gestational diabetes	6.5e-05	0.000168	CbGpPWpGaD
Bosutinib—PTK2B—Immune System—FGF2—gestational diabetes	6.49e-05	0.000168	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—LEP—gestational diabetes	6.49e-05	0.000168	CbGpPWpGaD
Bosutinib—HCK—Disease—FGF2—gestational diabetes	6.46e-05	0.000167	CbGpPWpGaD
Bosutinib—FYN—Innate Immune System—FGF2—gestational diabetes	6.42e-05	0.000167	CbGpPWpGaD
Bosutinib—PDGFRB—Adaptive Immune System—FGF2—gestational diabetes	6.4e-05	0.000166	CbGpPWpGaD
Bosutinib—MAP2K1—Innate Immune System—FGF2—gestational diabetes	6.39e-05	0.000166	CbGpPWpGaD
Bosutinib—BLK—Immune System—FGF2—gestational diabetes	6.34e-05	0.000164	CbGpPWpGaD
Bosutinib—FGR—Immune System—FGF2—gestational diabetes	6.32e-05	0.000164	CbGpPWpGaD
Bosutinib—EGFR—Developmental Biology—FGF2—gestational diabetes	6.28e-05	0.000163	CbGpPWpGaD
Bosutinib—LYN—Adaptive Immune System—FGF2—gestational diabetes	6.27e-05	0.000162	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—FGF2—gestational diabetes	6.21e-05	0.000161	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—MTNR1B—gestational diabetes	6.19e-05	0.000161	CbGpPWpGaD
Bosutinib—FYN—Adaptive Immune System—FGF2—gestational diabetes	6.17e-05	0.00016	CbGpPWpGaD
Bosutinib—PTK2—Developmental Biology—TNF—gestational diabetes	6.12e-05	0.000159	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—FGF2—gestational diabetes	6.1e-05	0.000158	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—FGF2—gestational diabetes	6.1e-05	0.000158	CbGpPWpGaD
Bosutinib—ERBB4—Disease—FGF2—gestational diabetes	6.08e-05	0.000158	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—RBP4—gestational diabetes	6.04e-05	0.000156	CbGpPWpGaD
Bosutinib—YES1—Developmental Biology—TNF—gestational diabetes	6.03e-05	0.000156	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—MTNR1B—gestational diabetes	5.97e-05	0.000155	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—GLS2—gestational diabetes	5.96e-05	0.000155	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—FGF2—gestational diabetes	5.89e-05	0.000153	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—RBP4—gestational diabetes	5.82e-05	0.000151	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—FGF2—gestational diabetes	5.81e-05	0.000151	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—LEP—gestational diabetes	5.61e-05	0.000145	CbGpPWpGaD
Bosutinib—EGFR—Innate Immune System—FGF2—gestational diabetes	5.55e-05	0.000144	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—LEP—gestational diabetes	5.53e-05	0.000143	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—FGF2—gestational diabetes	5.36e-05	0.000139	CbGpPWpGaD
Bosutinib—ERBB3—Disease—FGF2—gestational diabetes	5.36e-05	0.000139	CbGpPWpGaD
Bosutinib—LCK—Innate Immune System—FGF2—gestational diabetes	5.35e-05	0.000139	CbGpPWpGaD
Bosutinib—EGFR—Adaptive Immune System—FGF2—gestational diabetes	5.33e-05	0.000138	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—LEP—gestational diabetes	5.32e-05	0.000138	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—MTNR1B—gestational diabetes	5.28e-05	0.000137	CbGpPWpGaD
Bosutinib—PTK2—Immune System—FGF2—gestational diabetes	5.17e-05	0.000134	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—RBP4—gestational diabetes	5.15e-05	0.000134	CbGpPWpGaD
Bosutinib—LCK—Adaptive Immune System—FGF2—gestational diabetes	5.14e-05	0.000133	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—LEP—gestational diabetes	5.13e-05	0.000133	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—LEP—gestational diabetes	5.13e-05	0.000133	CbGpPWpGaD
Bosutinib—YES1—Immune System—FGF2—gestational diabetes	5.1e-05	0.000132	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—LEP—gestational diabetes	4.94e-05	0.000128	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—FGF2—gestational diabetes	4.93e-05	0.000128	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—FGF2—gestational diabetes	4.83e-05	0.000125	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—FGF2—gestational diabetes	4.74e-05	0.000123	CbGpPWpGaD
Bosutinib—MAP2K2—Developmental Biology—TNF—gestational diabetes	4.71e-05	0.000122	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—FGF2—gestational diabetes	4.55e-05	0.000118	CbGpPWpGaD
Bosutinib—SRC—Adaptive Immune System—FGF2—gestational diabetes	4.55e-05	0.000118	CbGpPWpGaD
Bosutinib—LYN—Developmental Biology—TNF—gestational diabetes	4.5e-05	0.000117	CbGpPWpGaD
Bosutinib—ABL1—Developmental Biology—TNF—gestational diabetes	4.48e-05	0.000116	CbGpPWpGaD
Bosutinib—FYN—Developmental Biology—TNF—gestational diabetes	4.43e-05	0.000115	CbGpPWpGaD
Bosutinib—MAP2K1—Developmental Biology—TNF—gestational diabetes	4.41e-05	0.000114	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—LEP—gestational diabetes	4.4e-05	0.000114	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—LEP—gestational diabetes	4.34e-05	0.000112	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—FGF2—gestational diabetes	4.26e-05	0.00011	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GGCT—gestational diabetes	4.2e-05	0.000109	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—FGF2—gestational diabetes	4.2e-05	0.000109	CbGpPWpGaD
Bosutinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	4.13e-05	0.000107	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—LEP—gestational diabetes	4.11e-05	0.000107	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—FGF2—gestational diabetes	4.04e-05	0.000105	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—FGF2—gestational diabetes	3.98e-05	0.000103	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—FGF2—gestational diabetes	3.9e-05	0.000101	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—FGF2—gestational diabetes	3.9e-05	0.000101	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—FGF2—gestational diabetes	3.88e-05	0.000101	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—LEP—gestational diabetes	3.87e-05	0.0001	CbGpPWpGaD
Bosutinib—EGFR—Developmental Biology—TNF—gestational diabetes	3.83e-05	9.92e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—FGF2—gestational diabetes	3.8e-05	9.86e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—FGF2—gestational diabetes	3.78e-05	9.81e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—FGF2—gestational diabetes	3.75e-05	9.74e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—FGF2—gestational diabetes	3.74e-05	9.7e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—FGF2—gestational diabetes	3.72e-05	9.65e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GLS2—gestational diabetes	3.67e-05	9.53e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—FGF2—gestational diabetes	3.67e-05	9.52e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—FGF2—gestational diabetes	3.58e-05	9.29e-05	CbGpPWpGaD
Bosutinib—FYN—Disease—FGF2—gestational diabetes	3.45e-05	8.96e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—FGF2—gestational diabetes	3.44e-05	8.91e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—LEP—gestational diabetes	3.39e-05	8.78e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—FGF2—gestational diabetes	3.34e-05	8.67e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—LEP—gestational diabetes	3.3e-05	8.57e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—FGF2—gestational diabetes	3.3e-05	8.55e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—NAMPT—gestational diabetes	3.27e-05	8.47e-05	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—TNF—gestational diabetes	3.27e-05	8.47e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—GCK—gestational diabetes	3.25e-05	8.42e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—LEP—gestational diabetes	3.24e-05	8.39e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—FGF2—gestational diabetes	3.23e-05	8.38e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—LEP—gestational diabetes	3.18e-05	8.26e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—LEP—gestational diabetes	3.17e-05	8.21e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—FGF2—gestational diabetes	3.13e-05	8.11e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—FGF2—gestational diabetes	3.12e-05	8.08e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—FGF2—gestational diabetes	2.98e-05	7.74e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—FGF2—gestational diabetes	2.94e-05	7.63e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—FGF2—gestational diabetes	2.88e-05	7.46e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—FGF2—gestational diabetes	2.76e-05	7.15e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—LEP—gestational diabetes	2.75e-05	7.13e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—LEP—gestational diabetes	2.65e-05	6.88e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—FGF2—gestational diabetes	2.57e-05	6.67e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—FGF2—gestational diabetes	2.55e-05	6.6e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—FGF2—gestational diabetes	2.51e-05	6.51e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—FGF2—gestational diabetes	2.46e-05	6.37e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—FGF2—gestational diabetes	2.42e-05	6.27e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—FGF2—gestational diabetes	2.41e-05	6.24e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CYP19A1—gestational diabetes	2.37e-05	6.16e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—LEP—gestational diabetes	2.35e-05	6.09e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—FGF2—gestational diabetes	2.09e-05	5.42e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—FGF2—gestational diabetes	2.01e-05	5.22e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—NAMPT—gestational diabetes	2.01e-05	5.22e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GCK—gestational diabetes	2e-05	5.19e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—FGF2—gestational diabetes	1.78e-05	4.62e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CYP19A1—gestational diabetes	1.46e-05	3.79e-05	CbGpPWpGaD
